Macrocyclic compounds and compositions useful as BACE...

Details Macrocyclic compounds and compositions useful as BACE... Macrocyclic compounds and compositions useful as BACE...

2011-08-30

2011-08-30

Ha, Julie (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S017700, C514S017800, C540S567000, C530S317000

Reexamination Certificate

active

08008250

ABSTRACT:
Macrocyclic compounds of the formula in which R1, R3, V1, V2, X1, X2, Y, Z, Ar, AA and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16, 17 or 18, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them are presented.

REFERENCES:
patent: 6969709 (2005-11-01), Pulley et al.
patent: 2003/0236199 (2003-12-01), Pulley et al.
patent: 2007/0072792 (2007-03-01), Auberson et al.
patent: 2008/0132477 (2008-06-01), Betschart et al.
patent: 2009/0029960 (2009-01-01), Betschart et al.
patent: 2009/0170878 (2009-07-01), Machauer
patent: 2009/0312370 (2009-12-01), Laumen et al.
patent: 2010/0022500 (2010-01-01), Auberson et al.
patent: 0 675 122 (1995-10-01), None
patent: WO 92/18490 (1992-10-01), None
patent: 02/100399 (2002-12-01), None
patent: 02/100856 (2002-12-01), None
patent: WO 2004/062625 (2004-07-01), None
patent: 2005/003106 (2005-01-01), None
patent: 2005/016876 (2005-02-01), None
patent: WO 2005/018545 (2005-03-01), None
patent: 2005/049585 (2005-06-01), None
patent: 2006/014944 (2006-02-01), None
patent: WO 2006/074940 (2006-07-01), None
patent: WO 2006/074950 (2006-07-01), None
patent: WO 2007/077004 (2007-07-01), None
Auberson, U.S. PTO Notice of Allowance, U.S. Appl. No. 10/577,260, Jun. 22, 2009, 8 pgs.
Auberson, U.S. PTO Office Action, U.S. Appl. No. 10/577,260, Feb. 27, 2008, 10 pgs.
Auberson, U.S. PTO Office Action, U.S. Appl. No. 10/577,260, Sep. 30, 2008, 14 pgs.
Betschart, U.S. PTO Office Action, U.S. Appl. No. 11/794,413, Feb. 4, 2010, 5 pgs.
Betschart, U.S. PTO Office Action, U.S. Appl. No. 11/794,413, Jul. 20, 2010, 16 pgs.
Betschart, U.S. PTO Office Action, U.S. Appl. No. 12/159,742, Sep. 8, 2010, 7 pgs.
Betschart, U.S. PTO Office Action, U.S. Appl. No. 12/159,742, Nov. 22, 2010, 12 pgs.
Chemical Abstracts No. 118:81414 (1992), 2 pgs.
Ripka et al., “Synthesis of Novel Cyclic Protease Inhibitors using Grubbs Olefin Metathesis”, Bioorganic & Medicinal Chemistry Letters, vol. 8 (1998), pp. 357-360.
Smith et al., “Design, Synthesis, and Activity of Conformationally-Constrained Macrocyclic Peptide-Based Inhibitors of Huv Protease”, Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 18 (1994), pp. 2217-2222.
Hardy, “A Hundred Years of Alzheimer's Disease Research”, Neuron, vol. 52 (2006), pp. 3-13.
Auberson, U.S. PTO Office Action, U.S. Appl. No. 12/566,928, Mar. 29, 2011, 14 pgs.
Betschart, U.S. PTO Notice of Allowance, U.S. Appl. No. 12/159,742, Mar. 29, 2011, 12 pgs.
Laumen, U.S. PTO Office Action, U.S. Appl. No. 12/374,467, Mar. 29, 2011, 13 pgs.
Laumen, U.S. PTO Restriction Requirement, U.S. Appl. No. 12/374,467, Jan. 25, 2011, 6 pgs.
Auberson, U.S. PTO Restriction Requirement, U.S. Appl. No. 12/566,928, Jan. 5, 2011, 7 pgs.
Betschart, U.S. PTO Notice of Allowance, U.S. Appl. No. 11/794,413, Jan. 18, 2011, 6 pgs.
Machauer, U.S. PTO Restriction Requirement, U.S. Appl. No. 12/374,469, Jun. 22, 2011, 5 pgs.

Affiliated with

Also associated with

Rating

Macrocyclic compounds and compositions useful as BACE... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic compounds and compositions useful as BACE..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic compounds and compositions useful as BACE... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2765985